Notice Type
Departmental
Classification of Medicines Pursuant to section 106 (1) of the Medicines Act 1981, I, G. R. Boyd, Chief Advisor, Regulation and Safety, acting under delegated authority, hereby declare the following: 1. The medicines listed in Schedule 1 to this notice are classified as prescription medicines. 2. The medicines listed in Schedule 2 to this notice are classified as restricted medicines. 3. The medicines listed in Schedule 3 to this notice are classified as pharmacy-only medicines. Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from biological or mineral sources. Unless specific reference is made otherwise, every reference applies also to medicines that are: (a) Preparations and admixtures containing any proportion of any substance listed in the notice; (b) Salts and esters of any substance listed in the notice; (c) Preparations or extracts of biological materials listed in the notice; (d) Salts or oxides of elements listed in the notice. Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using the free acid, base, alcohol or element unless specifically stated otherwise. Schedule 1 Prescription Medicines abacavir alkyl sulfonals amphomycin androisoxazole azelaic acid; except for dermal use bicalutamide bolandiol bolasterone bolazine boldenone (dehydrotestosterone) bolenol bolmantalate butylchloral hydrate 4-chloromethandienone calusterone candicidin captodiame capuride cefacetrile cefaloridine cefapirin chloralformamide chloral hydrate; except in topical preparations containing 2% or less chloralose chlorandrostenolone chloroform; for use in anaesthesia; except when specified elsewhere in the Schedules chloroxydienone chloroxymesterone (dehydrochloromethyltestosterone) clocortolone clofenamide clomocycline clostebol (4-chlorotestosterone) corticosterone cyclothiazide 2,4-dinitrochlorobenzene dehydrocorticosterone desoximetasone dextromethorphan; except when specified elsewhere in the Schedules diethylcarbamazine diflorasone dihydrolone dimethandrostanolone dimethazine edetic acid; except dicobalt edetate in preparations for the treatment of cyanide poisoning enestebol enflurane epitiostanol ethanolamine; in medicines for injection ether; for use in anaesthesia ethyl chloride; for inhalational anaesthesia ethyldienolone fluclorolone fluocortin formebolone formyldienolone furazabol hetacillin hydroxystenozol ivermectin lauromacrogol; in medicines for injection mebolazine mepitiostane mercury; except when specified elsewhere in the Schedules mesabolone mestanolone (androstalone) methacycline methandienone methandriol methenolone methyl androstanolone methyl clostebol methyl trienolone metolazone metribolone mibolerone mirtazapine mitobronitol mitomycin mupirocin niridazole norandrostenolone norbolethone norclostebol norethandrolone oleandomycin ovandrotone oxabolone oxacillin oxetacaine; except for internal use oxymesterone paramethasone paromomycin pentosan polysulfate sodium pertussis antigen phenacemide pheneticillin phenol; in medicines for injection phenylephrine; except in eye drops containing 2.5% or less when used in practice by a registered optometrist. pipobroman prasterone (dehydroepiandrosterone, dehydroisonandrosterone) praziquantel procaine penicillin propetandrol quinbolone quinethazone raloxifene raltitrexed roxibolone silandrone sodium cellulose phosphate sodium morrhuate; in medicines for injection stanolone stanozolol stenbolone sulfamonomethoxine sulfatroxazole sulfomyxin sulfonmethane teropterin testolactone thiambutosine thiazosulfone thioacetazone tolonium triclofos trimustine urethane (excluding its derivatives) valnoctamide viprinium virginiamycin Schedule 2 Restricted Medicines clotrimazole; for vaginal use econazole; for vaginal use folinic acid (leucovorin) isoconazole; for vaginal use leucovorin (folinic acid) miconazole; for vaginal use nystatin; for vaginal use tioconazole; for vaginal use Schedule 3 Pharmacy-only Medicines azelaic acid; for dermal use chloroform; in medicines other than for anaesthesia containing more than 0.5% cresols; in medicines containing more than 3% dextromethorphan; in liquid form containing more than 0.25% and not more than 0.3% and in solid dose form containing more than 15 milligrams and not more than 30 milligrams per dose form. ether; in medicines other than for anaesthesia containing more than 10% mercury; in topical preparations containing 0.5% or less oxetacaine; for internal use phenol; in medicines other than for injection containing more than 3% xylenols; in medicines containing more than 3% Medicines for General Sale Please note that the following medicines are no longer classified as prescription medicines, restricted medicines or pharmacy- only medicines. As such, they are now available for general sale. chloral hydrate; in topical preparations containing 2% or less chloroform; in medicines other than for anaesthesia containing 0.5% or less cresols; in medicines containing 3% or less dextromethorphan; in liquid form containing 0.25% or less and in solid dose form containing 15 milligrams or less per dose form edetic acid; in preparations containing dicobalt edetate for the treatment of cyanide poisoning ether; in medicines other than for anaesthesia containing 10% or less phenol; in medicines other than for injection containing 3% or less xylenols; in medicines containing 3% or less Dated this 21st day of May 1999. G. R. BOYD, Chief Adviser, Regulation and Safety.
Publication Date
3 Jun 1999

Notice Number

1999-go3872

Page Number

1482